ScholarIQanswers from OpenAlex & ORCID
Tsutomu Takeuchi
ResearcherPublications, citations & collaboration network
Tsutomu Takeuchi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Tsutomu Takeuchi have?
ScholarIQindexed works
Tsutomu Takeuchi has 1,971 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Tsutomu Takeuchi have?
ScholarIQcitation count
Tsutomu Takeuchi has 55,334 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Tsutomu Takeuchi?
ScholarIQh-index
Tsutomu Takeuchi has an h-index of 99 in OpenAlex.
What is the i10-index of Tsutomu Takeuchi?
ScholarIQi10-index
Tsutomu Takeuchi has an i10-index of 750 in OpenAlex.
What is the ORCID of Tsutomu Takeuchi?
ScholarIQorcid
The ORCID for Tsutomu Takeuchi is on the source record.
What is the OpenAlex record for Tsutomu Takeuchi?
ScholarIQopenalex
The OpenAlex for Tsutomu Takeuchi is on the source record.
What are the most-cited papers on Tsutomu Takeuchi?
ScholarIQmost cited works
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B. McInnes, Alexandre Sepriano, Ronald van Vollenhoven, Maarten de Wit, Daniel Aletaha, Martin Aringer, Johan Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Myrna Cardiel, Diederik De Cock, Cătălin Codreanu, Maurizio Cutolo, Christopher J Edwards, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques‐Eric Gottenberg, Merete Lund Hetland, T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher J Edwards, Kimme L Hyrich, Janet Pope, Savia de Souza, Tanja Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin Winthrop, Alejandro Balsa, Joan M. Bathon, Maya H Buch, Gerd R Burmester, Frank Buttgereit, Myrna Cardiel, Katerina Chatzidionysiou, Cătălin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques‐Eric Gottenberg, Espen A. Haavardsholm, Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Josef S Smolen, Ferdinand C. Breedveld, Gerd R Burmester, Vivian P. Bykerk, Maxime Dougados, Paul Emery, Tore K Kvien, M Victoria Navarro-Compán, Susan Oliver, Monika Schoels, Marieke Voshaar, Tanja Stamm, Michaela Stoffer, Tsutomu Takeuchi, Daniel Aletaha, José Luís Andreu, Martin Aringer, Martin Bergman, Neil Betteridge, Hans Bijlsma, Harald Burkhardt, Mario Cardiel, Bernard Combe, Patrick Durez, João Eurico Fonseca, Alan Gibofsky, Juan J. Gómez‐Reino, W. Graninger, Pekka Hannonen, Boulos Haraoui, Marios Kouloumas, Robert Landewé, E. Martín‐Mola, Peter Nash, Mikkel Østergaard, Andrew J.K. Östör, P. Scott Richards, Tuulikki Sokka‐Isler, Carter Thorne, Athanasios G. Tzioufas, Ronald van Vollenhoven, M. De Wit, Désirée van der Heijde
Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐Naive Patients With Moderately‐to‐Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Multicenter, Multi‐Country, Randomized, Double‐Blind, Active Comparator–Controlled Trial
Ronald van Vollenhoven, Tsutomu Takeuchi, Aileen L. Pangan, Alan Friedman, Mohamed‐Eslam F. Mohamed, Su Chen, Maureen Rischmueller, Ricardo Blanco, Ricardo Machado Xavier, Vibeke Strand